<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SGC Univ. of Toronto &#8211; openlabnotebooks.org</title>
	<atom:link href="https://thesgc.github.io/static-openlabnotebooks/category/laboratory/sgc-toronto/feed/" rel="self" type="application/rss+xml" />
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<description>A growing team of groundbreaking scientists around the world are now sharing their lab notebooks online</description>
	<lastBuildDate>Mon, 09 Sep 2019 14:13:00 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.9.11</generator>

<image>
	<url>https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/01/cropped-lab-jar02-32x32.png</url>
	<title>SGC Univ. of Toronto &#8211; openlabnotebooks.org</title>
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>PROTAC Virtual Screening: A Retrospective Screening Exercise</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/protac-virtual-screening-a-retrospective-screening-exercise/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/protac-virtual-screening-a-retrospective-screening-exercise/#respond</comments>
		<pubDate>Fri, 06 Sep 2019 21:10:26 +0000</pubDate>
		<dc:creator><![CDATA[Haresh Ajani]]></dc:creator>
				<category><![CDATA[Haresh Ajani]]></category>
		<category><![CDATA[In silico PROTACs design]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3434</guid>
		<description><![CDATA[In my previous post https://thesgc.github.io/static-openlabnotebooks/protein-protein-docking-for-protac-discovery/ I showed that HADDOCK was the best protein-protein docking tool among those I tested to predict how E3 ligases interact with their protein substrates. Here, I ask whether docking virtual libraries of PROTAC candidates to these E3 ligase – substrate protein interfaces can be used to predict which PROTACs are active. <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/protac-virtual-screening-a-retrospective-screening-exercise/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p style="text-align: justify;">In my previous post <a href="https://thesgc.github.io/static-openlabnotebooks/protein-protein-docking-for-protac-discovery/">https://thesgc.github.io/static-openlabnotebooks/protein-protein-docking-for-protac-discovery/</a> I showed that HADDOCK was the best protein-protein docking tool among those I tested to predict how E3 ligases interact with their protein substrates. Here, I ask whether docking virtual libraries of PROTAC candidates to these E3 ligase – substrate protein interfaces can be used to predict which PROTACs are active.</p>
<p style="text-align: justify;">The virtual screening method that I am using is as follows (Figure 1):</p>
<ul>
<li style="text-align: justify;">Use HADDOCK to dock the E3 ligase to the protein target and keep the ~40 best solutions (typically grouped in 5 to 9 clusters of structurally related binding poses)</li>
<li style="text-align: justify;">For each PROTAC candidate, tether the two chemical handles to their corresponding ligands in the protein-protein complexes generated by HADDOCK, and minimize the energy of the PROTAC while ignoring the proteins. This produces a selection of conformationally acceptable PROTACs: SELECTION 1</li>
<li style="text-align: justify;">Start from the conformationally acceptable PROTACs (SELECTION 1) and further minimize their energy, this time accounting for the surrounding proteins (PROTACs and side-chains within 5Å are kept flexible)</li>
</ul>
<p style="text-align: justify;">Step 2 and 3 are conducted 3 times independently, and all results are merged, so, for 10 PROTAC candidates, we will have 10 molecules x 40 prot-prot-interfaces x 3 repeats = 1200 binding poses.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Picture1.png" alt="" width="974" height="520" class="size-full wp-image-3436 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Picture1.png 974w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Picture1-300x160.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Picture1-768x410.png 768w" sizes="(max-width: 974px) 100vw, 974px" /></p>
<p>&nbsp;</p>
<p style="text-align: center;"><strong>Figure 1</strong>: Overview of the virtual PROTAC screen pipeline.</p>
<p>This screening pipeline is implemented in ICM (Molsoft, San Diego), and the corresponding script is attached to this <a href="https://zenodo.org/record/3403054#.XXZdNpNKhXg">Zenodo</a> post.</p>
<p>I tested this protocol against 5 test cases taken from the literature, and the details can be found on <a href="https://zenodo.org/record/3403054#.XXZdNpNKhXg">Zenodo</a>. Here is a summary table:</p>
<p>&nbsp;</p>
<p style="text-align: justify;">Two general observations can be made. First: in all test cases, the starting library of compounds for which we have experimental data is highly enriched in experimentally active molecules. Picking compounds at random, one has good chances of selecting active PROTACs. Two: in all 5 test cases, our top 3 scoring PROTACs out of the virtual screening pipeline are systematically active (see details in <a href="https://zenodo.org/record/3403054#.XXZdNpNKhXg">Zenodo</a>). In four out of 5 test cases, the library selected by virtual screening is enriched in active PROTACs, compared with the starting library, which is better than random. At this point, it is too early to know whether this is pure luck, or whether this reflects a valid virtual screening strategy.</p>
<p style="text-align: justify;">Considering how unreliable virtual screening of conventional small molecules to a crystal structure is (one can expect 95 inactives out of 100 compounds selected virtually when the stars are aligned), it seems almost ridiculous to dock PROTACs (large and floppy molecules) to predicted protein-protein interfaces. And yet, it is not unreasonable to expect that the multiple protein-protein docking poses generated by HADDOCK (or other protein-protein docking tools), while being all suboptimal (after all, these complexes do not form naturally), are structurally sufficiently sound to be stabilized by a PROTAC. Indeed, Nowak et al. clearly showed that different PROTACs could induce different binding poses between CRBN and BRD4<sup>BD1</sup> (Nowak <em>et al</em>. <em>Nat. Chem. Biol.</em> 14:706-714). If we accept this hypothesis, the PROTAC docking step should actually be more efficient than a regular virtual screening campaign, as the orientation of the two functional ends of the PROTACs are imposed by the protein complex, which considerably reduces the conformational space available to the PROTAC, and the chances to predict a wrong PROTAC binding pose. There is still room for getting things wrong, but not as much as one would expect considering the complexity of the system.</p>
<p style="text-align: justify;">Finally, an important factor I ignored so far is that some PROTAC candidates may induce the formation of a ternary complex in a biophysical assay, but still be inactive because they do not cross cell membranes. I will probably need to incorporate physico-chemical filters to account for this, following-up on work by Maple <em>et al. ( MedChemComm., <strong>2019,</strong> DOI: 10.1039/c9md00272c)</em> and Edmondson <em>et al.</em>(<em>Bioorg. Med. Chem. Lett.,</em> <strong>2019,</strong> 13:1555-1564) Another factor even more complex is that some compounds may induce the formation of a ternary structure that is not compatible with efficient ubiquitylation of the target.</p>
<p style="text-align: justify;">Two things are sure: we need more experimentally inactive PROTACs, and there is room for improvement.</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/protac-virtual-screening-a-retrospective-screening-exercise/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More Purifications</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/final-purifications/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/final-purifications/#respond</comments>
		<pubDate>Wed, 28 Aug 2019 15:56:46 +0000</pubDate>
		<dc:creator><![CDATA[Jacob McAuley]]></dc:creator>
				<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[Jacob McAuley]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3393</guid>
		<description><![CDATA[Back again. Two posts in one month! I know its crazy, but I’m just excited to tell you about the progress that is being made on this project. First things first, purifications. This week I have four more to tell you about. The first is GFP, and unlike all of my other posts, this is <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/final-purifications/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Back again. Two posts in one month! I know its crazy, but I’m just excited to tell you about the progress that is being made on this project. First things first, purifications. This week I have four more to tell you about.</p>
<p>The first is <a href="https://zenodo.org/record/3380341#.XWakIehKjcs">GFP</a>, and unlike all of my other posts, this is not because it interacts with HTT. At the moment we are trying to over express FLAG-Tagged HTT in a neuronal cell line. Growing tagged HTT is usually done in HEK293 cells although this isn&#8217;t a great cell line for physiological studies of HTT due to its improper localization. Neurons are quite a bit more sensitive, so extra care has to be taken to properly over-express this protein. Using conventional methods of over expression don’t really work due to the physical characteristics of tagged HTT, mainly its size. To get the protein into the cell we are considering following the example of Lambert, H.<em> et. al.(</em> <a href="https://doi.org/10.1139/o90-105"><em>https://doi.org/10.1139/o90-105</em></a><em>). </em>Described in this paper, is a method of electroporating cells to insert protein into the cell instead of DNA to express said protein. The GFP will be used as an optimization tool to ensure our electroporation method can successfully insert a protein into a neuronal cell.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/GFPPP-300x260.png" alt="" width="300" height="260" class="size-medium wp-image-3394 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/GFPPP-300x260.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/GFPPP.png 323w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p>&nbsp;</p>
<p>The other proteins that were purified pertained to my main project. They were P97, PIAS1, GIT1 and SP1. <a href="https://zenodo.org/record/3367290#.XWaj9OhKjcs">P97</a> was purified successfully resulting in a final yield of approximately 3 mg. <a href="https://zenodo.org/record/3380355#.XWajz-hKjcs">PIAS1</a> was unable to be successfully purified. Previously a shorter construct of PIAS1 was expressed in E. coli BL21 codon plus RIL but now we attempted an SF9 construct of full length PIAS1, although it seemed to have very poor expression in this system. GIT1 and SP1 were also unsuccessfully purified. As always, more detailed methods of purification can be found on Zenodo, any of the hyperlinks of the proteins will bring you to the respective Zenodo post.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/final-purifications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More Protein Purification</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/more-protein-purification/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/more-protein-purification/#respond</comments>
		<pubDate>Tue, 13 Aug 2019 14:46:04 +0000</pubDate>
		<dc:creator><![CDATA[Jacob McAuley]]></dc:creator>
				<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[Jacob McAuley]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3320</guid>
		<description><![CDATA[Hello again! It has been a while since my last post but that is not for lack of data. Over the past month I have been purifying like crazy, adding more proteins to out bank of possible interaction partners. As we are now in the final month of the project, I want to take this <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/more-protein-purification/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Hello again! It has been a while since my last post but that is not for lack of data. Over the past month I have been purifying like crazy, adding more proteins to out bank of possible interaction partners. As we are now in the final month of the project, I want to take this post and summarize all of the work that has been done so far.</p>
<p>This project set out with a goal of isolating putative interaction partners for use in interaction testing assays with HTT. As such, I have spent the summer harvesting and purifying proteins using different chromatography methods; including Nickel affinity and size exclusion chromatography. Below, I have an SDS analysis of all protein samples collected thus far.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/Purified-PPI-284x300.png" alt="" width="284" height="300" class="size-medium wp-image-3321 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/Purified-PPI-284x300.png 284w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/Purified-PPI.png 579w" sizes="(max-width: 284px) 100vw, 284px" /></p>
<p>To be more specific about my recent purifications; <a href="http://10.5281/zenodo.3367286">SQSTM1</a>, <a href="https://zenodo.org/record/3380353#.XWakYOhKjcs">GAPDH</a> and <a href="http://10.5281/zenodo.3367298">HIP1</a> were all recently grown and attempted to be purified. Sadly, the SQSTM1 and GAPDH resulted in no yield. SQSTM1 was expressed properly although the purification was not stringent enough, leading to an unusable product. GAPDH on the other hand seemed to have a problem with expression, unknowingly, I accidentally purified a contaminant it was discarded after Mass Spectrometry data showed it was a contaminant. HIP1 was a different story, purification by Nickel affinity and size exclusion chromatography proved successful, yielding almost 2 mg of protein. The detailed methods used of these purifications, as always, can be found on Zenodo. Each hyperlink on the protein name will take you to their respective Zenodo post.</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/more-protein-purification/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Project Overview: Overexpressing HTT in neuronal cells</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/project-overview-overexpressing-htt-in-neuronal-cells/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/project-overview-overexpressing-htt-in-neuronal-cells/#respond</comments>
		<pubDate>Tue, 06 Aug 2019 04:19:23 +0000</pubDate>
		<dc:creator><![CDATA[Victoria Vu]]></dc:creator>
				<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[Victoria Vu]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3260</guid>
		<description><![CDATA[My main project revolves around the E3 ligase UBE3A (I will be writing a project overview for this later), but I am also continuing some work in the same vein as Jolene Ho&#8217;s work looking at role of HTT in neurological disorders. HTT encodes a protein called huntingtin whose function is not known but appears <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/project-overview-overexpressing-htt-in-neuronal-cells/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>My main project revolves around the E3 ligase UBE3A (I will be writing a project overview for this later), but I am also continuing some work in the same vein as <a href="https://thesgc.github.io/static-openlabnotebooks/category/past-scientist/jolene-ho/">Jolene Ho&#8217;s work</a> looking at role of HTT in neurological disorders.</p>
<p>HTT encodes a protein called huntingtin whose function is not known but appears to be crucial to neuron function.  Mutant HTT is frequently associated with Huntington&#8217;s Disease (HD), where the 5&#8242; end of the <em>HTT</em> gene is observed to have an expanded CAG repeat region &#8211; the trinucleotide is repeated more times in individuals with HD than in normal individuals. In HD, mutant HTT is observed to affect neuronal function and structure leading to progressive neurodegeneration, however the exact disease mechanism is not well understood.</p>
<p>To study the function of HTT and the effects of mutant HTT protein <em>in vivo</em>, I will try to introduce trackable copies of <em>HTT </em>into mammalian cells, specifically neuronal cells. By overexpressing the HTT protein in varying amounts and with varying number of CAG repeats, we can try to elucidate the normal function of HTT in a non-disease context and examine how mutant HTT protein affects cell function and leads to neurodegeneration.</p>
<p>As seen in <a href="https://thesgc.github.io/static-openlabnotebooks/category/past-scientist/jolene-ho/">Jolene&#8217;s previous posts</a>, it is can be difficult to express such a large protein in cells. Jolene attempted to express HTT in <a href="https://thesgc.github.io/static-openlabnotebooks/overexpression-of-expanded-htt-in-brain-cancer-cell-lines/">two brain cancer cell lines</a>, but found limited success. I am using the same <a href="https://thesgc.github.io/static-openlabnotebooks/overexpressing-htt-in-mammalian-cells/">BacMAM virus system</a> previously established at the SGC and attempting to apply it in the widely used neuroblast cell line SH-SY5Y. The protocols for the experiments described below and additional data can be found on <a href="https://zenodo.org/record/3361015#.XUj8POhKiMo">Zenodo</a>.</p>
<p>With limited examples of the use of BacMAM in SH-SY5Y in the literature, I decided to test a range of virus amounts and included a BacMAM GFP control which I could visualize under the microscope to see how effective it was in SH-SY5Y. In line with <a href="https://thesgc.github.io/static-openlabnotebooks/overexpressing-htt-in-mammalian-cells/">Jolene&#8217;s optimization experiments</a> and a paper I found using BacMAM to overexpress wildtype and mutant LRRK2 implicated in Parkinson&#8217;s Disease  (PMID: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429506/">22952710</a>), I used up to 25% v/v of p3 (passage 3) BacMAM virus to transduce SH-SY5Y and included HEK293 for comparison.</p>
<p>The LRRK2 article (PMID: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429506/">22952710</a>) assayed cells for protein expression 48 hours post-transduction, so I thought I would get decent HTT expression within the same time-frame. I tracked GFP expression for 48 hours to get an overall idea of how effective the virus is in SH-SHY5. To detect HTT expression, I followed-up with FLAG-tag immunofluorescence (IF) in the SH-SY5Y (note: HEK293 don&#8217;t adhere very well and wash off easily so IF can&#8217;t be done with them). I find that GFP is very well expressed in both the HEK293 and SH-SY5Y cell lines after 48hrs, however, I did not detect any FLAG-tagged HTT in my IF (see RFP signal in figure below). This suggest that expression levels of the FLAG-tagged HTT from my BacMAM virus is likely too low to be detected using IF.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/BacMAM_HTT_48hrs-01-300x137.png" alt="" width="654" height="299" class="aligncenter wp-image-3285" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/BacMAM_HTT_48hrs-01-300x137.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/BacMAM_HTT_48hrs-01-768x350.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/BacMAM_HTT_48hrs-01-1024x467.png 1024w" sizes="(max-width: 654px) 100vw, 654px" /></p>
<p>I decided to repeat the transduction in a larger 24-well format and harvest cells for a western to see if I could detect any HTT expression. I also changed the harvest point to 3 days post-transduction as Jolene successfully in detected overexpressed HTT in HEK293 with a longer 3-day post-transduction expression period. I observed some SH-SHY5 cells began dying 2 days post-transduction, with more cells dying and lifting off in higher v/v of BacMAM virus. After 3 days, I was only able to harvest the cells with 5% BacMAM virus for my western as most of the cells at higher v/v BacMAM virus died.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01-300x148.png" alt="" width="675" height="333" class="aligncenter wp-image-3284" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01-300x148.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01-768x379.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01-1024x506.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01.png 1338w" sizes="(max-width: 675px) 100vw, 675px" /></p>
<p>In my western, I detected FLAG-tagged HTT in the positive controls (D1 &#8211; 23 CAG repeats, D2 &#8211; 54 CAG repeats), but I did not detect any in both my SH-SY5Y grown for 3 days and 6 days post-transduction. It is possible that 5% v/v BacMAM virus is too low, but before I can move forward with higher v/v, I need to optimize conditions for the transduction in SH-SY5Y so that fewer cells die. The SH-SY5Y cells may be dying from either too much virus, the side effects of overexpressing HTT, or incompatibility with the Sf9 media the BacMAM virus is in. Moving forward, I will have to test these possibilities and optimize transduction conditions to maximize overexpression HTT while reducing cell death.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/project-overview-overexpressing-htt-in-neuronal-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Purification of the HTT C-HEAT domain</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/#respond</comments>
		<pubDate>Fri, 02 Aug 2019 13:40:02 +0000</pubDate>
		<dc:creator><![CDATA[Claudia Alvarez]]></dc:creator>
				<category><![CDATA[Claudia Alvarez]]></category>
		<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3263</guid>
		<description><![CDATA[I am very excited to write my first post in open notebook. My post on Zenodo summarizes the results of my first ever purification of a huntingtin (HTT) domain. I was able to purify successfully the HTT C-HEAT domain encompassing residues 2088-3144. Figure 1. Anti-FLAG purification of the HTT C-HEAT domain. Eluted protein is seen <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>I am very excited to write my first post in open notebook. My post on <a href="https://zenodo.org/record/3358864#.XUQ673spA2w">Zenodo</a> summarizes the results of my first ever purification of a huntingtin (HTT) domain. I was able to purify successfully the HTT C-HEAT domain encompassing residues 2088-3144.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/C-TERM-FLAG-for-post-e1564753579324-281x300.png" alt="" class="alignnone wp-image-3269 size-medium" width="281" height="300" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/C-TERM-FLAG-for-post-e1564753579324-281x300.png 281w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/C-TERM-FLAG-for-post-e1564753579324-768x821.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/C-TERM-FLAG-for-post-e1564753579324.png 849w" sizes="(max-width: 281px) 100vw, 281px" /></p>
<p>Figure 1. Anti-FLAG purification of the HTT C-HEAT domain. Eluted protein is seen in the red box!</p>
<p>This purification was first done by <a href="http://labscribbles.com/">Dr. Rachel Harding</a> (<a href="https://zenodo.org/record/2628060#.XUQ4snspA2x">Zenodo</a>). Following her purification protocol, I obtained good yields of protein (0.45 mg of protein per L of Sp9 cells) which I immediately used to set crystal trays and to initiate biophysical characterization.</p>
<p>In future purifications, my aim is to improve purity as I noticed the sample was not very clean (low molecular weight proteins and nucleic acid). Further, I want to do a more stringent analysis to determine the most ideal buffer conditions for the sample using DSLS and DSF. I also would like to use SDS-PAGE and native PAGE to determine the progression of the limited proteolysis over time.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prioritizing Commercial Analogues of Previous USP5 ZnF-UBD Hits</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/#respond</comments>
		<pubDate>Wed, 31 Jul 2019 15:38:50 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3242</guid>
		<description><![CDATA[Hi all, it’s been a while since my last post; I’ve been busy in the lab purifying new protein constructs, developing a new assay and expanding the chemical series of my weak binding hits for USP5 ZnF-UBD, so there will be a couple of posts coming your way in the following weeks. This week, my <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Hi all, it’s been a while since my last post; I’ve been busy in the lab purifying new protein constructs, developing a new assay and expanding the chemical series of my weak binding hits for USP5 ZnF-UBD, so there will be a couple of posts coming your way in the following weeks.</p>
<p>This week, my post focuses on my efforts to expand the chemical series against USP5 ZnF-UBD to continue to understand the structure activity relationship (SAR) and improve potency. I used GLIDE to dock commercial analogues of hit compounds DAT00000194a and DAT00000201a (Table 1) as well as fragments from my selection of ligands from my work at <a href="https://thesgc.github.io/static-openlabnotebooks/virtual-screening-with-molecular-forecaster/">Molecular Forecaster (MFI).</a> The source library for the search for analogues of DAT00000194 and DAT00000201 was Enamine’s REAL database of 700 million chemically accessible compounds. You can see details of this work on <strong><a href="https://zenodo.org/record/3356885#.XUGzoOhKjIU">Zenodo</a>.</strong></p>
<p><strong>Table 1</strong>. USP5 ZnF-UBD Hits</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a-300x119.png" alt="" width="529" height="210" class="alignnone wp-image-3243" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a-300x119.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a-768x304.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a-1024x405.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a.png 1122w" sizes="(max-width: 529px) 100vw, 529px" /></p>
<p>20 commercial compounds were selected and ordered based on docking pose, protein-ligand interactions, docking score, chemical groups, and cost. For example, an analogue of DAT00000201a was chosen based on the hydrophobic and hydrogen bond interactions of the chemical group extending from the phenyl ring. The docked pose suggests a potential hydrogen bond interaction with residue D264 and hydrophobic interactions with residue M266 (Figure 1).</p>
<p>You can see some of the selected compounds at the end of this post, and download the sdf file!</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731b-300x254.png" alt="" width="588" height="498" class="wp-image-3245 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731b-300x254.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731b-768x651.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731b.png 1002w" sizes="(max-width: 588px) 100vw, 588px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. a) Analogue of DAT00000201a b) Surface representation of USP5 ZnF-UBD with DAT00000201a (cyan) and docked pose of analogue compound (tan) [PDB: 6DXH]; c) Ribbon representation of USP5 ZnF-UBD and docked pose of analogue compound [PDB: 6DXH]</p>
<p>It’ll be interesting to see how well the analogues bind to USP5 ZnF-UBD, and how the crystallized pose of the ligands will compare to the docked pose. When the compounds arrive in a couple of weeks, I’ll be testing these compounds using a surface plasmon resonance assay. Stay tuned!</p>
<table data-upload-id="file_upload:2cbb9b40-6f73-4a3b-9e6e-1365abb845a1">
<thead>
<tr>
<th>Structure Image</th>
<th>Smiles</th>
<th>Mol. Weight</th>
</tr>
</thead>
<tbody>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C([O-])CCC(=O)c1cccc(NS(=O)(=O)c2c[nH]c3ncccc23)c1</td>
<td>372.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>Cc1ccc(C(=O)[O-])cc1S(=O)(=O)Nc1cccc(C(=O)CCC(=O)[O-])c1</td>
<td>389.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>C[C@@H](CC(=O)c1cccc(-c2ccc3c(c2)CCCO3)c1)C(=O)[O-]</td>
<td>323.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>CN(c1ccc(S(C)(=O)=O)cc1)S(=O)(=O)c1ccc(C(=O)CCC(=O)[O-])cc1</td>
<td>424.5</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C([O-])CCC(=O)c1cccc(NS(=O)(=O)c2c[nH]c(C(=O)N3CCCC3)c2)c1</td>
<td>418.5</td>
</tr>
</tbody>
</table>
<p><a href="/wp-content/uploads/2019/07/3242_f6d556eb-46ae-498f-9daf-1d06810361fe.sdf">Download SDF file</a></p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Project Overview</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/project-overview/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/project-overview/#respond</comments>
		<pubDate>Wed, 24 Jul 2019 15:33:27 +0000</pubDate>
		<dc:creator><![CDATA[Claudia Alvarez]]></dc:creator>
				<category><![CDATA[Claudia Alvarez]]></category>
		<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3212</guid>
		<description><![CDATA[I joined the group of Dr. Cheryl Arrowsmith 2 months ago. Currently, I am working on the Huntington’s disease project along with Dr. Rachel Harding and Jacob McAuley. During these past two months, I have been learning how to purify huntingtin (HTT) protein and overall getting up to date with the project. A brief introduction <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/project-overview/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>I joined the group of Dr. Cheryl Arrowsmith 2 months ago. Currently, I am working on the Huntington’s disease project along with <a href="https://labscribbles.com/">Dr. Rachel Harding</a> and <a href="https://thesgc.github.io/static-openlabnotebooks/category/scientist/jacob-mcauley/">Jacob McAuley</a>. During these past two months, I have been learning how to purify huntingtin (HTT) protein and overall getting up to date with the project.</p>
<p>A brief introduction to the project: HTT is a 348 KDa protein that is vital for development <sup>1</sup>. HTT has a polyglutamine repeat at its N-terminus which is normally no longer than 35 repeats (Figure 1). When this number of repeats exceeds 38 repeats, it causes Huntington’s disease (HD), a dominantly inherited neurological disorder that occurs in adulthood and sometimes in children <sup>2</sup>. Thus, like many other neurological disorders such as Parkinson’s and Alzheimer’s disease, HD is also caused by a protein with an abnormal function in the cell. There are very limited treatments available for HD patients in part because there is little information about the function and structure of HTT and mutant HTT.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/Project-overview-post_3-284x300.jpg" alt="" class="alignnone size-medium wp-image-3227" width="284" height="300" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/Project-overview-post_3-284x300.jpg 284w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/Project-overview-post_3.jpg 718w" sizes="(max-width: 284px) 100vw, 284px" /></p>
<p>Figure 1. The huntingtin protein in normal population and in Huntington&#8217;s disease patients. Figure courtesy of <a href="https://labscribbles.com/">Dr. Rachel Harding</a>.</p>
<p>In the cell, HTT is thought to be involved in several important protein-protein interactions that are critical for cellular vesicular transport, endocytosis, autophagy and the regulation of transcription <sup>3,7</sup>. However, the complete picture of the function of HTT in the cell is yet not fully determined.</p>
<p>HTT is made up of three different domains. Two HEAT <sup>8,9</sup> (<u>H</u>untingtin, <u>E</u>longation factor 3, protein phosphatase 2<u>A</u>, <u>T</u>arget of rapamycin 1) domains at the N-terminus and C-terminus which are connected by a bridge. However, HTT has several disordered regions within these domains, which makes structural studies of HTT challenging. Recently, the cryo-EM structure of the protein was obtained making a huge step forward to understand more about HTT <sup>10</sup>. However, almost a quarter of the structure of HTT is still unknown in part due to the dynamic nature of this protein.</p>
<p>The main focus of my project is to obtain the 3D structure of the individual domains of the HTT protein, namely the N-terminal HEAT domain, the bridge and C-terminal HEAT domain. With this approach, we hope to better define structural elements in the protein. Further, studies with the individual domains will also be useful to understand what the role of each of the domains is within HTT. By learning about the structure and function of the individual domains, we can learn about HTT’s function inside the cell. I will be posting updates on the research progress so stay tuned!</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">1. F. Saudou and S. Humbert. <em>Neuron, </em>vol. 89, no. 5, pp. 910-926, doi: <a href="https://doi.org/10.1016/j.neuron.2016.02.003">https://doi.org/10.1016/j.neuron.2016.02.003</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">2. M. E. MacDonald<em> et al.</em>, &#8221; <em>Cell, </em>vol. 72, no. 6, pp. 971-983, 1993/03/26/ 1993, doi: <a href="https://doi.org/10.1016/0092-8674(93)90585-E">https://doi.org/10.1016/0092-8674(93)90585-E</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">3. F. Mochel and R. G. Haller. (2011)<em>The Journal of Clinical Investigation, </em>vol. 121, no. 2, pp. 493-499, doi: <a href="https://doi.org/10.1172/JCI45691">https://doi.org/10.1172/JCI45691</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">4. P. Harjes and E. E. Wanker. <em>Trends in Biochemical Sciences, </em>vol. 28, no. 8, pp. 425-433, 2003/08/01/ 2003, doi: <a href="https://doi.org/10.1016/S0968-0004(03)00168-3">https://doi.org/10.1016/S0968-0004(03)00168-3</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">5. S.-H. Li and X.-J. Li, <em>The Neuroscientist, </em>vol. 10, no. 5, pp. 467-475, 2004/10/01 2004, doi: <a href="https://doi.org/10.1177/1073858404266777">https://doi.org/10.1177/1073858404266777</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">6. J. P. Caviston and E. L. F. Holzbaur. <em>Trends in Cell Biology, </em>vol. 19, no. 4, pp. 147-155, 2009/04/01/ 2009, doi: <a href="https://doi.org/10.1016/j.tcb.2009.01.005">https://doi.org/10.1016/j.tcb.2009.01.005</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">7. <a href="https://oxfordmedicine.com/view/10.1093/med/9780199929146.001.0001/med-9780199929146-chapter-11">Z. Chiara and C. Elena. Oxford, UK: Oxford University Press</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">8. M. A. Andrade and P. Bork, <em>Nature Genetics, </em>vol. 11, no. 2, pp. 115-116, 1995/10/01 1995, <a href="https://doi.org/10.1038/ng1095-115">doi: 10.1038/ng1095-115</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">9. J. Perry and N. Kleckner,  <em>Cell, </em>vol. 112, no. 2, pp. 151-155, 2003, doi: <a href="https://doi.org/10.1016/S0092-8674(03)00033-3">10.1016/S0092-8674(03)00033-3</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">10. Q. Guo<em> et al.</em>, <em>Nature, </em>vol. 555, no. 7694, pp. 117-+, Mar 2018, <a href="https://doi.org/10.1038/nature25502">doi: 10.1038/nature25502</a>.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/project-overview/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Purification of putative huntingtin interacting proteins UBE2K, HAP1, NEDD4L</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/purification-of-putative-huntingtin-interacting-proteins-ube2k-hap1-nedd4l/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/purification-of-putative-huntingtin-interacting-proteins-ube2k-hap1-nedd4l/#respond</comments>
		<pubDate>Wed, 03 Jul 2019 14:21:36 +0000</pubDate>
		<dc:creator><![CDATA[Jacob McAuley]]></dc:creator>
				<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[Jacob McAuley]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3086</guid>
		<description><![CDATA[We are getting close to the midpoint of the summer and my project is well underway. With another week passed, I have more purifications to share. Again, I was attempting to purify proteins we think might interact with the huntingtin protein in neuronal cells. This time around was a little less successful than previous posts, <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/purification-of-putative-huntingtin-interacting-proteins-ube2k-hap1-nedd4l/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>We are getting close to the midpoint of the summer and my project is well underway. With another week passed, I have more purifications to share. Again, I was attempting to purify proteins we think might interact with the huntingtin protein in neuronal cells. This time around was a little less successful than previous posts, with the attempted purification of <a href="https://www.uniprot.org/uniprot/P61086">UBE2K</a>, <a href="https://www.uniprot.org/uniprot/P54257">HAP1</a>, and <a href="https://www.uniprot.org/uniprot/Q96PU5">NEDD4L</a>; sadly, only UBE2K was able to be successfully purified. These purifications followed the same general procedure that was detailed in<a href="https://thesgc.github.io/static-openlabnotebooks/production-and-purification-of-huntingtin-interaction-partners-continued/"> last week’s post</a>. To see a full outline of the methods used to attempt to purify these proteins, please visit my <a href="https://zenodo.org/deposit?page=1&amp;size=20">Zenodo</a>.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/UBE2K-300x260.png" alt="" width="300" height="260" class="size-medium wp-image-3087 alignleft" style="font-size: 1.5rem;" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/UBE2K-300x260.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/UBE2K-768x665.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/UBE2K.png 892w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Figure 1: Highlighted above is purified UBE2K protein that was run on an SDS Page.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/purification-of-putative-huntingtin-interacting-proteins-ube2k-hap1-nedd4l/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HDAC11 target engagement assay development in cells &#8211; CETSA</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/hdac11-target-engagement-assay-development-in-cells-cetsa/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/hdac11-target-engagement-assay-development-in-cells-cetsa/#comments</comments>
		<pubDate>Wed, 03 Jul 2019 14:12:37 +0000</pubDate>
		<dc:creator><![CDATA[Magdalena Szewczyk]]></dc:creator>
				<category><![CDATA[HDACs]]></category>
		<category><![CDATA[Magdalena Szewczyk]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3090</guid>
		<description><![CDATA[Hi Everyone, This is the first time I am going to share with you my research and I will start with the project I am currently working on, which is the development of cellular HDAC11 target engagement assay. HDAC11, the only member of class IV HDAC subfamily, was believed to be responsible for the deacetylation <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/hdac11-target-engagement-assay-development-in-cells-cetsa/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Hi Everyone,</p>
<p>This is the first time I am going to share with you my research and I will start with the project I am currently working on, which is the development of cellular HDAC11 target engagement assay. HDAC11, the only member of class IV HDAC subfamily, was believed to be responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). However, recent <em>in vitro</em> data indicates that HDAC11 is 10,000 times more efficient in lysine defatty-acylation than deacetylation (Fig1).</p>
<p>Fig1.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/substrateconversion-300x225.jpg" alt="" width="576" height="431" class="alignnone wp-image-3094" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/substrateconversion-300x225.jpg 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/substrateconversion-768x576.jpg 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/substrateconversion-350x263.jpg 350w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/substrateconversion-250x188.jpg 250w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/substrateconversion.jpg 960w" sizes="(max-width: 576px) 100vw, 576px" /></p>
<p>Target engagement assays allow us to test if potential  inhibitors enter the cell and interact with a target protein. Here, we are interested in developing this type of assay for HDAC11. Recently, novel potent and cell active HDAC11 inhibitors have been developed, which can be used for cellular assay validation (FT895 and compound 14). (PMID: 29776742). The activity of inhibitors in cells were tested using NanoBRET<img src="https://s.w.org/images/core/emoji/11/72x72/2122.png" alt="™" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Target Engagement  Assay, which measured the apparent affinity of test compounds by competitive displacement of proprietary compound labeled with a fluorescent tracer reversibly bound to  HDAC11 fused to Nanoluc luciferase. Currently we are in a process of development of our own fluorescent tracer based on published HDAC11 inhibitors and hopefully we will be able to use it for HDAC11 cellular assay development. However, since the tracer is not currently available I had to try other methods. One generic method for confirming target engagement is Cellular Thermal Stability Assays (CETSA) in which binding of the inhibitor increases the thermal stability of the target protein. I tested thermal stability of HDAC11 upon binding to published HDAC11 inhibitors using NanoLuc technology (PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/29937980">29937980</a>). In the assay you are transfecting cells with protein fused to Nanloluc luciferease, treat with inhibitors and measure bioluminescent signal after heat denaturation. Compound binding to the protein should lead to protein stabilization compared to controls. The system can be used in cells, which are not permeabilized and permeabilized with digitonin as a control (Fig2).</p>
<p>Fig2.</p>
<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004564/">ACS Med Chem Lett</a>. 2018 Jun 14; 9(6): 546–551</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/nanoluc-300x225.jpg" alt="" width="575" height="431" class="alignnone wp-image-3092" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/nanoluc-300x225.jpg 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/nanoluc-768x576.jpg 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/nanoluc-350x263.jpg 350w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/nanoluc-780x586.jpg 780w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/nanoluc-250x188.jpg 250w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/nanoluc.jpg 960w" sizes="(max-width: 575px) 100vw, 575px" /></p>
<p>In this experiment, I did not observe thermal stabilization of HDAC11-NanoLuc upon compounds FT895 (202) and 14 (201) treatment (Fig3). Experimental assay details are posted on <a href="https://zenodo.org/record/3267153#.XRyvVetKipo">Zenodo</a>.</p>
<p>Fig3.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/CETSA-HDAC11-300x225.jpg" alt="" width="656" height="492" class="alignnone wp-image-3093" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/CETSA-HDAC11-300x225.jpg 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/CETSA-HDAC11-768x576.jpg 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/CETSA-HDAC11-350x263.jpg 350w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/CETSA-HDAC11-780x586.jpg 780w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/CETSA-HDAC11-250x188.jpg 250w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/CETSA-HDAC11.jpg 960w" sizes="(max-width: 656px) 100vw, 656px" /></p>
<p>Next I am going to test if I can detect any changes in histones acetylation upon HDAC11 overexpression and inhibitors treatment. I will also update you with my effort to develop assay based on two findings:</p>
<ol>
<li>HDAC11 suppresses the thermogenic program of adipose tissue (PMID: 30089714).</li>
<li>HDAC11 regulates the expression of intereukin 10 (PMID: 19011628).</li>
</ol>
<p>&nbsp;</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/hdac11-target-engagement-assay-development-in-cells-cetsa/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Production and Purification of Huntingtin interaction partners continued</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/production-and-purification-of-huntingtin-interaction-partners-continued/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/production-and-purification-of-huntingtin-interaction-partners-continued/#respond</comments>
		<pubDate>Tue, 25 Jun 2019 18:23:10 +0000</pubDate>
		<dc:creator><![CDATA[Jacob McAuley]]></dc:creator>
				<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[Jacob McAuley]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3010</guid>
		<description><![CDATA[As the summer continues to progress, so does my project. After the last round of purification, detailed in my previous blog post, I am ready for another round. During this purification, I will be working with SH3G3 and PACN1. PACN1 is responsible for cytoskeletal remodeling through regulation of several other proteins, as well as neuronal <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/production-and-purification-of-huntingtin-interaction-partners-continued/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>As the summer continues to progress, so does my project. After the last round of purification, detailed in my <a href="https://thesgc.github.io/static-openlabnotebooks/first-round-of-huntingtin-interaction-partner-protein-production/">previous blog post</a>, I am ready for another round. During this purification, I will be working with <a href="https://www.uniprot.org/uniprot/Q9BY11">SH3G3</a> and <a href="https://www.uniprot.org/uniprot/Q99963">PACN1</a>. PACN1 is responsible for cytoskeletal remodeling through regulation of several other proteins, as well as neuronal vesicle endocytosis, among other things. It is thought that SH3G3 is more specialized in aiding endocytosis. Luckily, the purification of both proteins was successful, although that’s not to say everything went to plan.</p>
<p>The tags on these proteins allowed for multiple possible binding possibilities, meaning we had different avenues we could try for the purification. In the first attempt, we used SBP resin. In theory, the SBP would bind our protein of interest, allowing us to purify it, but in practice, the binding affinity was disappointingly low. In an attempt to salvage the purification, we then ran through a nickel purification, reverse nickel purification and size exclusion chromatography. Because of the design of the tag, our protein binds Nickel, but some proteins that occur naturally will also bind Nickel, so after collecting all of the nickel binding proteins, we can cut off the tag on our protein, using TEV, leaving it unable to bind Nickel. This means that is we mix nickel resin with the proteins; everything should bind the Nickel except our protein. After this, we ran it through a column with gel beads that contain tiny pores. Small proteins get trapped in the pores while larger proteins glide through, this gives us an additional way to purify our protein. For complete methods and data for <a href="https://zenodo.org/record/3256579#.XRJllIhKjcs">SH3G3</a> and <a href="https://zenodo.org/record/3256589#.XRJlr4hKjcs">PACN1</a> purifications, look to my posts on Zenodo.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/production-and-purification-of-huntingtin-interaction-partners-continued/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
